These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 27637905

  • 1. Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity.
    Bissa M, Quaglino E, Zanotto C, Illiano E, Rolih V, Pacchioni S, Cavallo F, De Giuli Morghen C, Radaelli A.
    Antiviral Res; 2016 Oct; 134():182-191. PubMed ID: 27637905
    [Abstract] [Full Text] [Related]

  • 2. Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain.
    Bissa M, Pacchioni SM, Zanotto C, De Giuli Morghen C, Illiano E, Granucci F, Zanoni I, Broggi A, Radaelli A.
    Virus Res; 2013 Dec 26; 178(2):374-82. PubMed ID: 24050999
    [Abstract] [Full Text] [Related]

  • 3. L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines.
    Pacchioni SM, Bissa M, Zanotto C, Morghen Cde G, Illiano E, Radaelli A.
    J Transl Med; 2013 Apr 11; 11():95. PubMed ID: 23578094
    [Abstract] [Full Text] [Related]

  • 4. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A, Wilson RL, Kirkwood-Watts DL, King DS, Warren TK, Lund SA, Brown LL, Krupkin AK, Vandermay E, Weimers W, Honeychurch KM, Grosenbach DW, Jones KF, Hruby DE.
    J Virol; 2008 Apr 11; 82(7):3517-29. PubMed ID: 18199639
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.
    Hooper JW, Thompson E, Wilhelmsen C, Zimmerman M, Ichou MA, Steffen SE, Schmaljohn CS, Schmaljohn AL, Jahrling PB.
    J Virol; 2004 May 11; 78(9):4433-43. PubMed ID: 15078924
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys.
    Grandpre LE, Duke-Cohan JS, Ewald BA, Devoy C, Barouch DH, Letvin NL, Reinherz EL, Baden LR, Dolin R, Seaman MS.
    Vaccine; 2009 Mar 04; 27(10):1549-56. PubMed ID: 19168105
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.
    Golden JW, Josleyn MD, Hooper JW.
    Vaccine; 2008 Jun 25; 26(27-28):3507-15. PubMed ID: 18485547
    [Abstract] [Full Text] [Related]

  • 11. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge.
    Hooper JW, Golden JW, Ferro AM, King AD.
    Vaccine; 2007 Feb 26; 25(10):1814-23. PubMed ID: 17240007
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge.
    Mucker EM, Golden JW, Hammerbeck CD, Kishimori JM, Royals M, Joselyn MD, Ballantyne J, Nalca A, Hooper JW.
    J Virol; 2022 Feb 09; 96(3):e0150421. PubMed ID: 34851148
    [Abstract] [Full Text] [Related]

  • 14. Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.
    Meseda CA, Campbell J, Kumar A, Garcia AD, Merchlinsky M, Weir JP.
    PLoS One; 2013 Feb 09; 8(6):e67984. PubMed ID: 23785523
    [Abstract] [Full Text] [Related]

  • 15. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.
    Pulford DJ, Gates A, Bridge SH, Robinson JH, Ulaeto D.
    Vaccine; 2004 Sep 03; 22(25-26):3358-66. PubMed ID: 15308360
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intranasal immunization with recombinant Vaccinia virus Tiantan harboring Zaire Ebola virus gp elicited systemic and mucosal neutralizing antibody in mice.
    Xie L, Zai J, Yi K, Li Y.
    Vaccine; 2019 May 31; 37(25):3335-3342. PubMed ID: 31076161
    [Abstract] [Full Text] [Related]

  • 18. Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.
    Hooper JW, Ferro AM, Golden JW, Silvera P, Dudek J, Alterson K, Custer M, Rivers B, Morris J, Owens G, Smith JF, Kamrud KI.
    Vaccine; 2009 Dec 11; 28(2):494-511. PubMed ID: 19833247
    [Abstract] [Full Text] [Related]

  • 19. A novel, killed-virus nasal vaccinia virus vaccine.
    Bielinska AU, Chepurnov AA, Landers JJ, Janczak KW, Chepurnova TS, Luker GD, Baker JR.
    Clin Vaccine Immunol; 2008 Feb 11; 15(2):348-58. PubMed ID: 18057181
    [Abstract] [Full Text] [Related]

  • 20. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.
    Stott EJ, Taylor G, Ball LA, Anderson K, Young KK, King AM, Wertz GW.
    J Virol; 1987 Dec 11; 61(12):3855-61. PubMed ID: 3316707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.